Cargando…

Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant

Detalles Bibliográficos
Autores principales:	Louis, Guillaume, Goetz, Christophe, Mellati, Nouchan, Dunand, Paul, Picard, Yoann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141690/ https://www.ncbi.nlm.nih.gov/pubmed/34033926 http://dx.doi.org/10.1016/j.accpm.2021.100890

Ejemplares similares

501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro
por: Liu, Haolin, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets
por: Riddell, Shane, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Variants of Concern Alpha (B.1.1.7) vs. Beta (B.1.351) in Critically Ill Patients: A Multicenter Cohort Study
por: Louis, Guillaume, et al.
Publicado: (2022)

Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant
por: Ngo, Son Tung, et al.
Publicado: (2021)

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK
por: Tang, Julian W., et al.
Publicado: (2021)

Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants’ spike protein–an in silico analysis
por: Pokhrel, Suman, et al.
Publicado: (2021)

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
por: Liu, Haolin, et al.
Publicado: (2021)

Detection of SARS-CoV-2 variant 501Y.V2 in Comoros Islands in January 2021
por: N. Agoti, Charles, et al.
Publicado: (2021)

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
por: Li, Qianqian, et al.
Publicado: (2021)

Efficiency of transmission-based precautions (TBPs) against SARS-CoV-2 501Y.V2 variant transmissibility in the ICU
por: Schortgen, Frédérique, et al.
Publicado: (2021)

Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2
por: Saade, Carla, et al.
Publicado: (2021)

501Y.V2 spike protein resists the neutralizing antibody in atomistic simulations
por: Ngo, Son Tung
Publicado: (2022)

Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2
por: Huang, Baoying, et al.
Publicado: (2021)

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2021)

Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy
por: Novazzi, Federica, et al.
Publicado: (2021)

Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India
por: Yadav, Pragya D., et al.
Publicado: (2021)

Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh
por: Sarkar, M. Murshed Hasan, et al.
Publicado: (2021)

Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

Prognosis of patients with acute respiratory failure due to the SARS-CoV-2 501Y.V2 variant: a multicenter retrospective matched cohort study
por: Puech, Bérénice, et al.
Publicado: (2022)

Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant
por: Maclot, François, et al.
Publicado: (2021)

Possible Role of Accessory Proteins in the Viral Replication for the 20I/501Y.V1 (B.1.1.7) SARS CoV-2 Variant
por: Nyayanit, Dimpal A., et al.
Publicado: (2021)

Characteristics and outcomes of SARS-COV 2 critically ill patients after emergence of the variant of concern 20H/501Y.V2: A comparative cohort study
por: Aries, Philippe, et al.
Publicado: (2022)

In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD Interface
por: Villoutreix, Bruno O., et al.
Publicado: (2021)

Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium
por: Touret, Franck, et al.
Publicado: (2021)

Outbreak of SARS-CoV-2 Lineage 20I/501Y.V1 in a Nursing Home Underlines the Crucial Role of Vaccination in Both Residents and Staff
por: Orsi, Andrea, et al.
Publicado: (2021)

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
por: Gaymard, Alexandre, et al.
Publicado: (2021)

SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
por: Huang, Hongyan, et al.
Publicado: (2021)

Synergistic infection of BrYV and PEMV 2 increases the accumulations of both BrYV and BrYV-derived siRNAs in Nicotiana benthamiana
por: Zhou, Cui-Ji, et al.
Publicado: (2017)

Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage
por: Colson, Philippe, et al.
Publicado: (2021)

Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus
por: Tuncel, Gulten, et al.
Publicado: (2022)

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
por: Li, Rong, et al.
Publicado: (2021)

ICU strain and outcome in COVID-19 patients—A multicenter retrospective observational study
por: Demoule, Alexandre, et al.
Publicado: (2022)

A novel single nucleotide polymorphism assay for the detection of N501Y SARS-CoV-2 variants
por: Sandoval Torrientes, M., et al.
Publicado: (2021)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
por: Vercueil, Colin, et al.
Publicado: (2021)

Clinical Characteristics of Patients with SARS-CoV-2 N501Y Variants in General Practitioner Clinic in Japan
por: Hanafusa, Mariko, et al.
Publicado: (2021)

In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
por: Çubuk, Hasan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4j6ea32bedbk4qen8tdhvoe2k